Global Mrna Therapeutics Contract Development & Manufacturing Market Size & Outlook
Global mrna therapeutics contract development & manufacturing market, 2021-2030 (US$M)
Related Markets
Global mrna therapeutics contract development & manufacturing market highlights
- The global mrna therapeutics contract development & manufacturing market generated a revenue of USD 4,142.8 million in 2023 and is expected to reach USD 8,354.0 million by 2030.
- The market is expected to grow at a CAGR (2024 - 2030) of 10.5% by 2030.
- In terms of segment, infectious diseases accounted for a revenue of USD 4,142.8 million in 2023.
- Infectious Diseases is the most lucrative indication segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2023.
- Country-wise, South Korea is expected to register the highest CAGR from 2024 to 2030.
Global data book summary
| Market revenue in 2023 | USD 4,142.8 million |
| Market revenue in 2030 | USD 8,354.0 million |
| Growth rate | 10.5% (CAGR from 2023 to 2030) |
| Largest segment | Infectious diseases |
| Fastest growing segment | Infectious Diseases |
| Historical data covered | 2021 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Infectious Diseases |
Other key industry trends
- In terms of revenue, the North America accounted for 37.0% of the global mrna therapeutics contract development & manufacturing market in 2023.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2030.
- By country, South Korea is the fastest growing regional market and is projected to reach USD 163.1 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
MRNA Therapeutics Contract Development & Manufacturing Market Scope
MRNA Therapeutics Contract Development & Manufacturing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Global mrna therapeutics contract development & manufacturing market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to mrna therapeutics contract development & manufacturing market will help companies and investors design strategic landscapes.
Infectious diseases was the largest segment with a revenue share of 100% in 2023. Horizon Databook has segmented the Global mrna therapeutics contract development & manufacturing market based on infectious diseases covering the revenue growth of each sub-segment from 2021 to 2030.
- Global MRNA Therapeutics Contract Development & Manufacturing Indication Outlook (Revenue, USD Million, 2021-2030)
- Infectious Diseases
- Metabolic & Genetic Diseases
- Cardiovascular & Cerebrovascular Diseases
- Global MRNA Therapeutics Contract Development & Manufacturing Application Outlook (Revenue, USD Million, 2021-2030)
- Viral Vaccines
- Protein Replacement Therapies
- Cancer Immunotherapies
- Global MRNA Therapeutics Contract Development & Manufacturing End Use Outlook (Revenue, USD Million, 2021-2030)
- Biotech Companies
- Pharmaceutical Companies
- Government & Academic Research Institutes
Reasons to subscribe to Global mrna therapeutics contract development & manufacturing market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global mrna therapeutics contract development & manufacturing market databook
-
Our clientele includes a mix of mrna therapeutics contract development & manufacturing market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global mrna therapeutics contract development & manufacturing market , including forecasts for subscribers. This global databook contains high-level insights into Global mrna therapeutics contract development & manufacturing market from 2021 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Global mrna therapeutics contract development & manufacturing market size, by region, 2021-2030 (US$M)
Top 10 countries: Mrna therapeutics contract development & manufacturing market size, 2023 (US$M)
Global mrna therapeutics contract development & manufacturing market share, by indication, 2023 & 2030 (%, US$M)
Mrna therapeutics contract development & manufacturing market: Opportunity assessment by country
Global mrna therapeutics contract development & manufacturing market, by region, 2023 (US$M)
Global mrna therapeutics contract development & manufacturing market size, by region, 2021-2030 (US$M)
| Indication | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | CAGR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | 3,197.7 | 2,674.4 | 1,533.0 | 1,646.7 | 1,885.3 | 2,042.4 | 2,229.7 | 2,477.9 | 2,803.9 | 3,228.0 | 11.2% |
| Europe | 2,492.2 | 2,055.2 | 1,161.6 | 1,230.0 | 1,323.9 | 1,442.2 | 1,585.1 | 1,766.3 | 2,008.1 | 2,336.2 | 10.5% |
| Asia Pacific | 2,198.1 | 1,805.7 | 1,015.1 | 1,067.8 | 1,082.4 | 1,180.7 | 1,302.7 | 1,465.2 | 1,682.9 | 1,979.5 | 10.0% |
| Latin America | 553.3 | 454.0 | 255.0 | 267.9 | 275.3 | 298.5 | 327.0 | 365.3 | 416.4 | 484.8 | 9.6% |
| MEA | 386.3 | 317.3 | 178.2 | 187.3 | 180.4 | 196.5 | 216.4 | 242.8 | 278.0 | 325.5 | 9.0% |
| Overall | 8,827.6 | 7,306.6 | 4,142.9 | 4,399.7 | 4,747.3 | 5,160.3 | 5,660.8 | 6,317.5 | 7,189.3 | 8,354.0 | 10.5% |
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
